Terms: = Endocrine gland cancer AND FLCN, BHD, 201163, ENSG00000154803, MGC23445, MGC17998, FLCL AND Treatment
3 results:
1. Germline- and Somatic-Inactivating flcn Variants in Parathyroid cancer and Atypical Parathyroid Tumors.
Jha S; Welch J; Tora R; Lack J; Warner A; Del Rivero J; Sadowski SM; Nilubol N; Schmidt LS; Linehan WM; Weinstein LS; Simonds WF; Agarwal SK
J Clin Endocrinol Metab; 2023 Sep; 108(10):2686-2698. PubMed ID: 36935552
[TBL] [Abstract] [Full Text] [Related]
2. Primary mediastinal seminoma with leiomyosarcoma: a rare case report.
Qi Y; Dong C; Cui W; Da L; Li E; Liu Y; Song F
Cell Mol Biol (Noisy-le-grand); 2022 Feb; 67(5):104-108. PubMed ID: 35818265
[TBL] [Abstract] [Full Text] [Related]
3. Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (flcn).
Lu X; Boora U; Seabra L; Rabai EM; Fenton J; Reiman A; Nagy Z; Maher ER
Oncogene; 2014 Feb; 33(8):956-65. PubMed ID: 23416984
[TBL] [Abstract] [Full Text] [Related]
